Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview

About

Dr. Mukesh Nandave is an In-charge Director of the School of Pharmaceutical Sciences Associate Dean (Research) and head of the Department of Pharmacology and Pharmaceutical Biotechnology at Delhi Pharmaceutical Sciences and Research University Govt. of NCT of Delhi New Delhi India. He has earlier served as associate professor and head of the Department of Pharmacology at NMIMS University Mumbai (2010-2017). He has also worked as a research scientist in the Medical Affairs and Clinical Research Department of Ranbaxy Research Laboratories (currently known as Sun Pharmaceutical Industries Limited Gurugram). Dr. Nandave earned his Ph. D. in pharmacology from AIIMS Delhi and received his post-doctoral training from the Division of Cardiothoracic Surgery the Ohio State University Medical Center Columbus USA. For more than 20 years Dr. Nandave has investigated the role of nutraceuticals herbomineral formulations and phytoconstituents for myocardial ischemia & reperfusion injury diabetes obesity and pain management. His lab received more than 3.5 crore total funding from Govt. (DBT DST ICMR and AYUSH) as well as industry (Pharmazz Dabur Fertis India Charak Pharma Madhavbaug and Sandu Pharma). He has published over 100 papers in peer-reviewed national and international journals books and book chapters. Dr. Nandave has received numerous awards including the Distinguished Leadership Award of International Academy of Cardiovascular Sciences; Prof. S. C. Lahiri Oration and G. Achari Gold Medal by Indian Pharmacological Society; Association of Pharmaceutical Teachers of India (APTI) Young Pharmacy Teacher of the Year Award Early Investigator Award by International Society for Heart Research Prof. Duggirala Visweswaram & Prof. Sreemantula Satyanarayana Prize; Best Research Output of the Year for 2014-2015 2013-2014 and 2012-2013 Award of SVKM's NMIMS University. Dr. Nandave is secretary general of the International Academy of Cardiovascular Sciences (IACS)-India section and treasurer of the Society for Promotion and Research of Cardiovascular Sciences (SPARCS). He is a life member of various professional bodies including the International Society for Heart Research (ISHR) the International Academy of Cardiovascular Sciences (IACS); the Indian Pharmacological Society (IPS); the Indian Pharmaceutical Association (IPA); the Association of Physiologist and Pharmacologist of India (APPI); Association of Pharmaceutical Teachers of India (APTI); and Society for Ethnopharmacology.